Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Conference News ESC 2025

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

Michael O'Riordan

September 10, 2025

News Daily News

CV Risk Modest for Most Cancer Survivors in Large Danish Registry

L.A. McKeown

June 17, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2024

Shelley Wood

December 03, 2024

News Conference News AHA 2024

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

Shelley Wood

November 14, 2024

News Daily News

Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows

L.A. McKeown

October 09, 2024

News Opinion Editor's Corner ACC 2024

What’s Going to Be Hot at ACC 2024

Shelley Wood

April 01, 2024

News Conference News ACC 2023

STOP-CA: Atorvastatin Curbs Heart Function Decline During Chemotherapy

L.A. McKeown

March 04, 2023

News Opinion Editor's Corner ACC 2023

What’s Going to Be Hot at ACC/WCC 2023?

Shelley Wood

February 27, 2023

News Daily News

Global Cardio-Oncology Viewpoints ‘Contextualize’ ESC Guidelines

L.A. McKeown

December 12, 2022

News Daily News

Trials of New Cancer Drugs Failing to Address Potential CV Risks

Todd Neale

February 10, 2020

News Daily News

Young Survivors of Childhood Cancer Have Higher, Earlier Risk of CVD Events

L.A. McKeown

August 30, 2019

News Daily News

AHA Releases Scientific Statement on Breast Cancer and CVD

L.A. McKeown

February 01, 2018

News Conference News ESC 2016

New Cardio-Oncology Position Statement Reviews Cardiovascular Side Effects of Cancer Therapies and Calls for Further Study

Shelley Wood

August 27, 2016

News Daily News

Fatal Cardiac Events No Higher With Aromatase Inhibitors for Breast Cancer Therapy

L.A. McKeown

April 21, 2016

News Daily News

Anthracycline-Based Chemotherapy Linked to Valve Disease, Even in Absence of Radiation

L.A. McKeown

February 16, 2016

News Daily News

Cardio-Oncology Offers Fellows the Opportunity to Venture Into the ‘Wild West’

L.A. McKeown

February 15, 2016

News Daily News

Many Childhood Cancer Survivors Have Silent Cardiac Conditions

Yael L. Maxwell

January 06, 2016

Advertisement

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

CV Risk Modest for Most Cancer Survivors in Large Danish Registry

TCTMD’s Top 10 Most Popular Stories for November 2024

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows

What’s Going to Be Hot at ACC 2024

STOP-CA: Atorvastatin Curbs Heart Function Decline During Chemotherapy

What’s Going to Be Hot at ACC/WCC 2023?

Global Cardio-Oncology Viewpoints ‘Contextualize’ ESC Guidelines

Trials of New Cancer Drugs Failing to Address Potential CV Risks

Young Survivors of Childhood Cancer Have Higher, Earlier Risk of CVD Events

AHA Releases Scientific Statement on Breast Cancer and CVD

New Cardio-Oncology Position Statement Reviews Cardiovascular Side Effects of Cancer Therapies and Calls for Further Study

Fatal Cardiac Events No Higher With Aromatase Inhibitors for Breast Cancer Therapy

Anthracycline-Based Chemotherapy Linked to Valve Disease, Even in Absence of Radiation

Cardio-Oncology Offers Fellows the Opportunity to Venture Into the ‘Wild West’

Many Childhood Cancer Survivors Have Silent Cardiac Conditions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content